Join
Live feed
·
INSIDERFilingvia Quantisnow
Viracta Therapeutics Inc. logo

SEC Form 4: Royston Ivor converted options into 25,219 shares and sold $53,656 worth of shares (13,379 units at $4.01), increasing direct ownership by 2% to 612,770 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIRX (Viracta Therapeutics Inc.) and more on Quantisnow.